Savara, Inc. (SVRA)

5.36 -0.10 (-1.83%) USD  |  NASDAQ  |  Sep 03, 16:00
5.36 0.00 (0.00%) After-Hours: 19:36
More

Savara Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for SVRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to 2007. Start Trial.
Date Value
December 31, 2020 --
December 31, 2016 --
December 31, 2010 --
Date Value
December 31, 2009 --
December 31, 2008 --
December 31, 2007 --

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Insmed, Inc. Upgrade
United Therapeutics Corp. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
SELLAS Life Sciences Group, Inc. --